Revvity Announces Financial Results for the Third Quarter of 2026

What happened

Revvity reported third-quarter 2026 revenue of $729 million, up from $699 million a year earlier, and GAAP earnings per share of $0.56 versus $0.41. GAAP operating income rose to $95 million from $82 million, while adjusted earnings per share increased to $1.38 from $1.18.

Confirmed

Global impact / market context

Higher revenue and operating income indicate that more sales translated into reported operating profit, while both GAAP and adjusted earnings per share also increased. If these improvements persist, they could support the company’s cash generation and investment capacity, although this report alone does not establish future performance.

Analyst inference

The results show year-over-year improvement in the reported quarter, including higher operating profit margins, which measure operating income as a share of revenue. Revvity also has a pending agreement to sell its China diagnostics business, so future reported results may reflect a changed business mix if the deal closes.

Analyst inference

What to watch

1. Compare revenue and operating income in later reports with these year-earlier figures to see whether sales growth continues to translate into higher operating profit. Analyst inference
2. The company’s agreement to divest China IDX is expected to close by the end of 2027, subject to customary closing conditions and regulatory approvals. Confirmed
3. Watch for later detail on China IDX’s contribution and the effect of its eventual sale, since it represented about 6% of fiscal 2025 revenue. Analyst inference

Evidence

• Original source link unavailable